SEARCH

Recent UK IPO stats show a significant increase in patent applications relating to carbon capture, usage and storage technology in recent years.

Supplementary Protection Certificates (SPCs) can provide up to five years’ extra patent protection for specific pharmaceutical products. The regulations are complex and the financial stakes high, resulting in multiple referrals to the Court of Justice of the European Union.

Alexander Ramsay, Chairman of the UPC Preparatory Committee is of the view that the London question will not delay the start of the UPC. 

Although it has its limitations, the number of European patent applications that originate from a country can be taken as an indicator of its R&D productivity. While it may not give us the precision we’d like, it provides a good measure by which to compare the UK with other European nations.

A question in the European Parliament to the Commission has raised the question of whether the UPC is compatible with certain aspects of EU law.

In a referral from German infringement proceedings brought by Ferrari against Mansory Design and its CEO, the CJEU has confirmed the conditions in which unregistered Community design protection is available for part of a product.